Filing Details
- Accession Number:
- 0001567619-18-003282
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-28 17:11:26
- Reporting Period:
- 2018-09-27
- Accepted Time:
- 2018-09-28 17:11:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636282 | Aeglea Biotherapeutics Inc. | AGLE | Pharmaceutical Preparations (2834) | 464312787 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1709258 | Aaron Schuchart | C/O Aeglea Biotherapeutics, Inc. 901 S. Mopac Expressway, Suite 250 Austin TX 78746 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-09-27 | 100 | $9.55 | 8,400 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-09-27 | 5,900 | $9.50 | 2,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Billionaire Hedge Funds
